Catalent signs agreement with Johnson & Johnson to be US manufacturing partner for lead COVID-19 vaccine candidate

Catalent has signed agreement with Johnson & Johnson to be US manufacturing partner for lead COVID-19 vaccine candidate. (Credit: dianakuehn30010 from Pixabay)